Eko

Digital stethoscopes and cardiac screening

Eko builds FDA-cleared digital stethoscopes and AI analysis used by hundreds of thousands of clinicians on millions of patients worldwide, helping detect cardiac and pulmonary disease with greater accuracy at the point of examination. Catching structural heart disease during a routine listen — rather than after symptoms send someone to a specialist — is where the diagnostic gain actually sits. The company holds more than eight FDA clearances including novel ones, was named by TIME in 2025 among the world's top healthcare technology companies, and its products are used at prestigious health systems globally.